Long­time biotech vet An­drew Hirsch is tak­ing the top job at C4 — and he clear­ly has some big plans

Four years af­ter An­drew Hirsch tied the last loose end on Bind’s bank­rupt­cy pack­age and shipped to Agios as its CFO, he is back at the helm.

Af­ter the mar­ket closed on Tues­day, we learned that Hirsch is tak­ing the CEO post at C4 Ther­a­peu­tics, which is mak­ing every ef­fort nec­es­sary to do the win­dow dress­ing for a ma­jor league biotech IPO. He’s tak­ing the place of An­drew Phillips, who hit the ex­it 2 years af­ter he was pro­mot­ed from CSO to CEO.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER